The 8th Annual eCOA Forum and Patient-Centric User Group
Dec. 10, 2019 – Dec. 11, 2019 • Philadelphia, PA
Make your voice heard surrounded by industry peers focused on eCOA, eConsent, and patient-centric technology!
Join clinical operations leaders from over 45 companies including AbbVie, AstraZeneca, Biogen, BMS, GSK, Lilly, Otsuka, Sage, Sanofi, and Merck at the Franklin Institute in Philadelphia, PA on December 10-11 to discuss essential issues in eCOA, eConsent, and more.
Complimentary for study sponsors and CROs of all sizes and knowledge levels, this year's eCOA Forum is comprised of insightful case study sessions, interactive roundtable discussions such as:
- eCOA trends for 2020 and beyond (e.g. virtual trials, sensors & wearables, BYOD)
- Evolving regulatory considerations on clinical trials
- The impact of eConsent and Patient Engagement
- Previews of exciting new advances in patient-facing technology
- Benefits of involving patients early in trial design, and more!
In addition, this year's eCOA Forum is proud to present our two key-note speakers, Kayla Redig and Sarah Denger as they share their experiences surrounding the "Young Adult Cancer Experience."
|What:||The 8th Annual eCOA Forum and Patient-Centric User Group|
|When:||The Franklin Institute
222 N. 20th Street, Philadelphia, PA 19103 When: December 10-11, 2019
|Who:||Clinical operations leaders from over 45 companies including AbbVie, AstraZeneca, Biogen, BMS, GSK, Lilly, Otsuka, Sage, Sanofi, and Merck|
|Why:||Because you understand the value of eCOA in clinical trials today and want to be at the forefront of innovation, identify best practices, discuss the clinical trial climate, and network with peers from across the country.|